IHC analysis which was performed in 296 glioma patients also demonstrated that 89.5% were AEG-1 positive cases among which 51.7% were identified with high AEG-1 expression and 48.3% with low expression (p < 0.001). The gene discussed is MTDH; the disease is central nervous system cancer.